# Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors

> **NCT05544292** · — · COMPLETED · sponsor: **Diakonhjemmet Hospital** · enrollment: 69 (actual)

## Conditions studied

- Immune-related Adverse Event

## Interventions

- **OTHER:** Antiinflammatory/DMARDs

## Key facts

- **NCT ID:** NCT05544292
- **Lead sponsor:** Diakonhjemmet Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-05
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05544292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05544292, "Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05544292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*